| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/05/2007 | CN101031569A Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 09/04/2007 | US7265111 inhibitors of lipolysis, as cardioprotective agents or they may be of value in the therapy of diabetes |
| 09/04/2007 | CA2306958C Process for the synthesis of chloropurine intermediates |
| 08/30/2007 | US20070203159 Purine compounds |
| 08/30/2007 | US20070203090 N-pyrazole A2A receptor agonists |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1558615B1 Purine compounds and use thereof as cannabinoid receptor ligands |
| 08/29/2007 | CN101027303A Imidazo 4,5-dpyrimidines, their uses and methods of preparation |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN101023748A Adenine plant growth regulator and preparing method thereof |
| 08/29/2007 | CN101023747A Plant growth regulator and synthesizing method therefor |
| 08/28/2007 | US7262164 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/23/2007 | WO2007065595A3 Xanthine derivatives, processes for preparing them and their uses |
| 08/23/2007 | US20070197784 illumination or heating 2(R)-Benzoyloxymethyl-[1,3]dioxolane-4(R)-carboxylic acid in the presence of diacetoxy iodobenzene and iodine, to from Benzoic acid 4(R,S)-acetoxy-[1,3]dioxolan-2(R)-ylmethyl ester, used for modifying of purine or pyrimidine bases; antitumor or anticarcinogenic agents |
| 08/23/2007 | US20070197564 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 08/23/2007 | US20070197563 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase |
| 08/23/2007 | US20070197559 Aryl substituted purine analogues |
| 08/23/2007 | US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds |
| 08/23/2007 | US20070197528 analgesic. especially acute, chronic and/or neuropathic pain; epilepsy and other CNS-related disorders as well as for neuroprotection or cardioprotection; 9-benzyl-8-(cyclopentylamine)-6-(4-nitrobenzyl-mercaptopurine |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/22/2007 | EP1660498B1 Process for the preparation of (1s,4r)-cis-4-[2-amino-6-chloro-9h-purin-9-yl]-2-cyclopentene-1-methanol |
| 08/22/2007 | EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/21/2007 | US7259159 Vitronectin receptor antagonists for treating and preventing osteoporosis, bone disorders |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/21/2007 | CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
| 08/16/2007 | WO2007092213A2 Inhibitors of e1 activating enzyme |
| 08/16/2007 | US20070191380 Kinase inhibitor scaffolds and methods for their preparation |
| 08/16/2007 | US20070191293 Inhibitors of E1 activating enzymes |
| 08/16/2007 | US20070190071 9-Substituted 8-oxoadenine compound |
| 08/16/2007 | CA2639924A1 Inhibitors of e1 activating enzymes |
| 08/15/2007 | CN101016299A Process for preparing purine derivatives |
| 08/15/2007 | CN101016298A Improved preparation process of 8-chlorotheophylline |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/14/2007 | US7256196 2-(Mono- or polyhalophenoxy- or anilino)-8,9-substituted purines, e.g., N-8-(2-Chlorophenyl)-9-methyl-N-2-(tetrahydro-pyran-4-yl)-9H-purine-2,8-diamine and [2-(2,6-Difluorophenoxy)-9-ethyl-9H-purin-8-yl]-(fluorophenyl)-amine |
| 08/09/2007 | US20070185141 Thiamine composition for enhancement of physical and mental energy, and related method |
| 08/09/2007 | US20070185064 2-Aminopurine Analogs Having HSP90-Inhibiting Activity |
| 08/09/2007 | US20070185063 Seven-membered ring nucleosides |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN101012228A Method of preparing antivirotic entecavir hydrate |
| 08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
| 08/02/2007 | WO2006048427A8 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/01/2007 | EP1812454A2 Chemical synthesis of s-adenosyl-l-methionine with enrichment of (s,s)-isomer |
| 08/01/2007 | EP1812438A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 08/01/2007 | EP1812004A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1812003A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1294722B1 Methods of synthesis for 9-substituted hypoxanthine derivatives |
| 08/01/2007 | CN1329393C New purine derivatives |
| 07/26/2007 | WO2007071393A3 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 07/26/2007 | US20070173483 Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors |
| 07/26/2007 | CA2637385A1 Compounds for the treatment of inflammatory disorders |
| 07/25/2007 | EP1809613A2 Methods of making 2,6-diaryl piperidine derivatives |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | CN1327826C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 07/25/2007 | CN101003550A Nucleotide compound in halogenating adenine class, synthetic method, medical appliction |
| 07/25/2007 | CN101003536A Entecavir salt, and preparation |
| 07/24/2007 | US7247721 Materials and methods for binding nucleic acids to surfaces |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives |
| 07/24/2007 | CA2230350C Combination preparation for use in dementia |
| 07/19/2007 | US20070167655 Method for the production of tetrahydrogeranylacetone |
| 07/19/2007 | US20070167468 Substituted bicyclic 8-pyrr0lidinoxanthines, methods for their production, pharmaceutical formulations and their use |
| 07/18/2007 | EP1807430A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 07/18/2007 | EP1807429A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | CA2170879C Diagnostic uses of hydrazinoadenosines |
| 07/12/2007 | WO2007021937A3 Unsaturated heterocyclic derivatives |
| 07/12/2007 | US20070161663 Agents for treating migraine |
| 07/12/2007 | US20070161629 A1 Adenosine Receptor Antagonists |
| 07/11/2007 | EP1805196A1 Substituted adenines and the use thereof |
| 07/11/2007 | EP1805181A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 07/11/2007 | EP1805180A1 Xanthine derivatives with hm74a receptor activity |
| 07/11/2007 | CN1997644A Aryl substituted purine analogues |
| 07/11/2007 | CN1995042A Substituted 1,2,3- triazolepyridine compound with HIV-resistant activity, preparation method and uses |
| 07/10/2007 | US7241890 Heat shock protein 90 inhibitors; breast cancer, melanomas; inflammation, infectious diseases, autoimmune disorders, ischemia |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/05/2007 | WO2007075572A2 Orally active purine-based inhibitors of heat shock protein 90 |
| 07/05/2007 | WO2007074632A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
| 07/05/2007 | WO2007074213A1 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155746 Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155658 Complexed via melamine derivative and optionally polyarginine or a polymer of glutamine and asparagine; RNA interference |
| 07/05/2007 | CA2634723A1 Orally active purine-based inhibitors of heat shock protein 90 |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238700 A2B adenosine receptor antagonists |
| 07/03/2007 | US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity |
| 07/03/2007 | CA2188306C Process for the diastereoselective synthesis of nucleoside analogues |
| 06/28/2007 | WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | WO2007071393A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 06/28/2007 | US20070149555 Prophylatic and/or therapeutic agents for chronic musculoskeletal pain |
| 06/28/2007 | US20070149523 Thiazole Analogues and Uses Thereof |
| 06/28/2007 | CA2669503A1 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 06/28/2007 | CA2631721A1 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | CN1323057C Process for the preparation of (1S,4R) or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene and its derivatives or its salts |